Cytokine networks in the infected lung

References

• Thompson WW, Shay DK, Weintraub E et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA289(2), 179–186 (2003).
   PubMed Web of Science ®Google Scholar
• Koth LL, Alex B, Hawgood S et al. Integrin β6 mediates phospholipid and collectin homeostasis by activation of latent TGF-β1. Am. J. Respir. Cell. Mol. Biol.37(6), 651–659 (2007).
   PubMed Web of Science ®Google Scholar
• Landsman L, Jung S. Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J. Immunol.179(6), 3488–3494 (2007).
   PubMed Web of Science ®Google Scholar
• Taut K, Winter C, Briles DE et al. Macrophage turnover kinetics in the lungs of mice infected with Streptococcus pneumoniae. Am. J. Respir. Cell. Mol. Biol.38(1), 105–113 (2008).
   Google Scholar
• Hajjar AM, Harowicz H, Liggitt HD, Fink PJ, Wilson CB, Skerrett SJ. An essential role for non-bone marrow-derived cells in control of Pseudomonas aeruginosa pneumonia. Am. J. Respir. Cell. Mol. Biol.33(5), 470–475 (2005).
   Google Scholar
• Moore TA, Moore BB, Newstead MW, Standiford TJ. γδ-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumonia. J. Immunol.165(5), 2643–2650 (2000).
   PubMed Web of Science ®Google Scholar
• Chan CW, Crafton E, Fan HN et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med.12(2), 207–213 (2006).
   PubMed Web of Science ®Google Scholar
• Hoek KL, Cassell GH, Duffy LB, Atkinson TP. Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells. J. Allergy Clin. Immunol.109(3), 470–476 (2002).
   PubMedGoogle Scholar
• Suzuki T, Chow CW, Downey GP. Role of innate immune cells and their products in lung immunopathology. Int. J. Biochem. Cell Biol.40(6–7), 1348–1361 (2008).
   PubMed Web of Science ®Google Scholar
• Bhan U, Lukacs NW, Osterholzer JJ et al. TLR9 is required for protective innate immunity in Gram-negative bacterial pneumonia: role of dendritic cells. J. Immunol.179(6), 3937–3946 (2007).
   Google Scholar
• Osterholzer JJ, Curtis JL, Polak T et al. CCR2 mediates conventional dendritic cell recruitment and the formation of bronchovascular mononuclear cell infiltrates in the lungs of mice infected with Cryptococcus neoformans. J. Immunol.181(1), 610–620 (2008).
   PubMedGoogle Scholar
• Osterholzer JJ, Ames T, Polak T et al. CCR2 and CCR6, but not endothelial selectins, mediate the accumulation of immature dendritic cells within the lungs of mice in response to particulate antigen. J. Immunol.175(2), 874–883 (2005).
   PubMed Web of Science ®Google Scholar
• Tovey MG, Lallemand C, Thyphronitis G. Adjuvant activity of type I interferons. Biol. Chem DOI: 10.1515/BC.2008.051 (2008) (Epub ahead of print).
   Google Scholar
• Narni-Mancinelli E, Campisi L, Bassand D et al. Memory CD8+ T cells mediate antibacterial immunity via CCL3 activation of TNF/ROI+ phagocytes. J. Exp. Med.204(9), 2075–2087 (2007).
   PubMed Web of Science ®Google Scholar
• Darwich L, Coma G, Pena R et al. Secretion of interferon-γ by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18. Immunology DOI: 10.1111/j.1365-2567.2008.02905.x (2008) (Epub ahead of print).
   Google Scholar
• Deng JC, Zeng X, Newstead M et al. STAT4 is a critical mediator of early innate immune responses against pulmonary Klebsiella infection. J. Immunol.173(6), 4075–4083 (2004).
   PubMed Web of Science ®Google Scholar
• Rivera A, Chen CC, Ron N, Dougherty JP, Ron Y. Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. Int. Immunol.13(12), 1583–1593 (2001).
   PubMed Web of Science ®Google Scholar
• Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett.85(2), 85–95 (2003).
   PubMed Web of Science ®Google Scholar
• Franchi L, Park JH, Shaw MH et al. Intracellular NOD-like receptors in innate immunity, infection and disease. Cell. Microbiol.10(1), 1–8 (2008).
   PubMed Web of Science ®Google Scholar
• Takeda K, Akira S. Toll-like receptors. In: Current Protocols In Immunology. Chapter 14, Unit 14.12 (2007).
   Google Scholar
• Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature406(6797), 782–787 (2000).
   PubMed Web of Science ®Google Scholar
• Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett.85(2), 85–95 (2003).
   PubMed Web of Science ®Google Scholar
• Henning LN, Azad AK, Parsa KV, Crowther JE, Tridandapani S, Schlesinger LS. Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. J. Immunol.180(12), 7847–7858 (2008).
   PubMed Web of Science ®Google Scholar
• Park JS, Svetkauskaite D, He Q et al. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem.279(9), 7370–7377 (2004).
   PubMed Web of Science ®Google Scholar
• Hedl M, Li J, Cho JH, Abraham C. Chronic stimulation of NOD2 mediates tolerance to bacterial products. Proc. Natl Acad. Sci. USA104(49), 19440–19445 (2007).
   PubMed Web of Science ®Google Scholar
• Rosenstiel P, Jacobs G, Till A, Schreiber S. NOD-like receptors: ancient sentinels of the innate immune system. Cell. Mol. Life Sci.19, 19 (2008).
   Google Scholar
• Martinon F, Agostini L, Meylan E, Tschopp J. Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr. Biol.14(21), 1929–1934 (2004).
   PubMed Web of Science ®Google Scholar
• Kishore U, Greenhough TJ, Waters P et al. Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol. Immunol.43(9), 1293–1315 (2006).
   PubMed Web of Science ®Google Scholar
• Steele C, Marrero L, Swain S et al. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 β-glucan receptor. J. Exp. Med.198(11), 1677–1688 (2003).
   PubMed Web of Science ®Google Scholar
• Steele C, Rapaka RR, Metz A et al. The β-glucan receptor Dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog.1(4), E42 (2005).
   PubMed Web of Science ®Google Scholar
• Mehrad B, Standiford TJ. Role of cytokines in pulmonary antimicrobial host defense. Immunol. Res.20(1), 15–27 (1999).
   PubMed Web of Science ®Google Scholar
• Standiford TJ, Kunkel SL, Phan SH, Rollins BJ, Strieter RM. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J. Biol. Chem.266(15), 9912–9918 (1991).
   PubMed Web of Science ®Google Scholar
• Standiford TJ, Kunkel SL, Basha MA et al. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J. Clin. Invest.86(6), 1945–1953 (1990).
   PubMed Web of Science ®Google Scholar
• Keane J, Shurtleff B, Kornfeld H. TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-γ independent manner. Tuberculosis (Edinb.)82(2–3), 55–61 (2002).
   PubMed Web of Science ®Google Scholar
• Benini J, Ehlers EM, Ehlers S. Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55-gene-deficient mice aerogenically infected with highly virulent Mycobacterium avium. J. Pathol.189(1), 127–137 (1999).
   Google Scholar
• Deepe GS Jr, Gibbons RS. T cells require tumor necrosis factor-α to provide protective immunity in mice infected with Histoplasma capsulatum. J. Infect. Dis.193(2), 322–330 (2006).
   PubMedGoogle Scholar
• Kwon YS, Kim EJ, Lee SH et al. Decreased cytokine production in patients with nontuberculous mycobacterial lung disease. Lung185(6), 337–341 (2007).
   PubMed Web of Science ®Google Scholar
• Netea MG, Brouwer AE, Hoogendoorn EH et al. Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon-γ therapy. Clin. Infect. Dis.39(9), E83–E87 (2004).
   PubMed Web of Science ®Google Scholar
• Mancini G, Erario L, Gianfreda R et al. Tuberculosis and Legionella pneumophila pneumonia in a patient receiving anti-tumour necrosis factor-α (anti-TNF-α) treatment. Clin. Microbiol. Infect.13(10), 1036–1037 (2007).
   Google Scholar
• Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. Fungal infections complicating tumor necrosis factor α blockade therapy. Mayo Clin. Proc.83(2), 181–194 (2008).
   PubMed Web of Science ®Google Scholar
• Imaizumi K, Sugishita M, Usui M, Kawabe T, Hashimoto N, Hasegawa Y. Pulmonary infectious complications associated with anti-TNFα therapy (infliximab) for rheumatoid arthritis. Intern. Med.45(10), 685–688 (2006).
   Web of Science ®Google Scholar
• Salvana EM, Cooper GS, Salata RA. Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infliximab-treated patients. J. Infect.55(6), 484–487 (2007).
   PubMedGoogle Scholar
• Kafka D, Ling E, Feldman G et al. Contribution of IL-1 to resistance to Streptococcus pneumoniae infection. Int. Immunol.20(9), 1139–1146 (2008).
   PubMed Web of Science ®Google Scholar
• Fremond CM, Togbe D, Doz E et al. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J. Immunol.179(2), 1178–1189 (2007).
   PubMed Web of Science ®Google Scholar
• Kolsuz M, Erginel S, Alatas O et al. Acute phase reactants and cytokine levels in unilateral community-acquired pneumonia. Respiration70(6), 615–622 (2003).
   Google Scholar
• Akarsu S, Kurt AN, Dogan Y, Yilmaz E, Godekmerdan A, Aygun AD. The differential diagnostic values of cytokine levels in pleural effusions. Mediators Inflamm.2005(1), 2–8 (2005).
   PubMedGoogle Scholar
• Quinton LJ, Jones MR, Robson BE, Simms BT, Whitsett JA, Mizgerd JP. Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia. Am. J. Respir. Cell. Mol. Biol.38(6), 699–706 (2008).
   PubMed Web of Science ®Google Scholar
• Quinton LJ, Jones MR, Simms BT et al. Functions and regulation of NF-κB RelA during pneumococcal pneumonia. J. Immunol.178(3), 1896–1903 (2007).
   PubMedGoogle Scholar
• Cooper AM, Solache A, Khader SA. Interleukin-12 and tuberculosis: an old story revisited. Curr. Opin. Immunol.19(4), 441–447 (2007).
   PubMed Web of Science ®Google Scholar
• Trinchieri G, Pflanz S, Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity19(5), 641–644 (2003).
   PubMed Web of Science ®Google Scholar
• Tateda K, Moore TA, Deng JC et al. Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia. J. Immunol.166(5), 3355–3361 (2001).
   Google Scholar
• Walter MJ, Kajiwara N, Karanja P, Castro M, Holtzman MJ. Interleukin 12 p40 production by barrier epithelial cells during airway inflammation. J. Exp. Med.193(3), 339–351 (2001).
   PubMed Web of Science ®Google Scholar
• Magram J, Connaughton SE, Warrier RR et al. IL-12-deficient mice are defective in IFN γ production and type 1 cytokine responses. Immunity4(5), 471–481 (1996).
   PubMed Web of Science ®Google Scholar
• Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med.186(1), 39–45 (1997).
   PubMed Web of Science ®Google Scholar
• Newton CA, Perkins I, Widen RH, Friedman H, Klein TW. Role of Toll-like receptor 9 in Legionella pneumophila-induced interleukin-12 p40 production in bone marrow-derived dendritic cells and macrophages from permissive and nonpermissive mice. Infect. Immun.75(1), 146–151 (2007).
   PubMed Web of Science ®Google Scholar
• Ruan S, McKinley L, Zheng M et al. Interleukin-12 and host defense against murine Pneumocystis pneumonia. Infect. Immun.76(5), 2130–2137 (2008).
   PubMed Web of Science ®Google Scholar
• Huang J, Wang MD, Lenz S, Gao D, Kaltenboeck B. IL-12 administered during Chlamydia psittaci lung infection in mice confers immediate and long-term protection and reduces macrophage inflammatory protein-2 level and neutrophil infiltration in lung tissue. J. Immunol.162(4), 2217–2226 (1999).
   Google Scholar
• Happel KI, Dubin PJ, Zheng M et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med.202(6), 761–769 (2005).
   PubMed Web of Science ®Google Scholar
• Greenberger MJ, Kunkel SL, Strieter RM et al. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J. Immunol.157(7), 3006–3012 (1996).
   PubMed Web of Science ®Google Scholar
• Ivanov S, Bozinovski S, Bossios A et al. Functional relevance of the IL-23-IL-17 axis in lungs in vivo. Am. J. Respir. Cell. Mol. Biol.36(4), 442–451 (2007).
   PubMedGoogle Scholar
• Joyee AG, Qiu H, Fan Y, Wang S, Yang X. Natural killer T cells are critical for dendritic cells to induce immunity in Chlamydial pneumonia. Am. J. Respir. Crit. Care Med.178(7), 745–756 (2008).
   Google Scholar
• Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol.22, 891–928 (2004).
   PubMed Web of Science ®Google Scholar
• Zeng X, Moore TA, Newstead MW, Deng JC, Lukacs NW, Standiford TJ. IP-10 mediates selective mononuclear cell accumulation and activation in response to intrapulmonary transgenic expression and during adenovirus-induced pulmonary inflammation. J. Interferon Cytokine Res.25(2), 103–112 (2005).
   PubMedGoogle Scholar
• Strassburg A, Droemann D, van Zandbergen G, Kothe H, Dalhoff K. Enhanced PMN response in chronic bronchitis and community-acquired pneumonia. Eur. Respir. J.24(5), 772–778 (2004).
   Google Scholar
• Tsai WC, Strieter RM, Mehrad B, Newstead MW, Zeng X, Standiford TJ. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect. Immun.68(7), 4289–4296 (2000).
   PubMed Web of Science ®Google Scholar
• Winter C, Taut K, Srivastava M et al. Lung-specific overexpression of CC chemokine ligand (CCL) 2 enhances the host defense to Streptococcus pneumoniae infection in mice: role of the CCL2–CCR2 axis. J. Immunol.178(9), 5828–5838 (2007).
   PubMed Web of Science ®Google Scholar
• Mehrad B, Wiekowski M, Morrison BE et al. Transient lung-specific expression of the chemokine KC improves outcome in invasive aspergillosis. Am. J. Respir. Crit. Care Med.166(9), 1263–1268 (2002).
   PubMed Web of Science ®Google Scholar
• Abul H, Abul A, Khan I, Mathew TC, Ayed A, Al-Athary E. Levels of IL-8 and myeloperoxidase in the lungs of pneumonia patients. Mol. Cell. Biochem.217(1–2), 107–112 (2001).
   Google Scholar
• Lindell DM, Standiford TJ, Mancuso P, Leshen ZJ, Huffnagle GB. Macrophage inflammatory protein 1α/CCL3 is required for clearance of an acute Klebsiella pneumoniae pulmonary infection. Infect. Immun.69(10), 6364–6369 (2001).
   PubMed Web of Science ®Google Scholar
• Stumbles PA, Strickland DH, Pimm CL et al. Regulation of dendritic cell recruitment into resting and inflamed airway epithelium: use of alternative chemokine receptors as a function of inducing stimulus. J. Immunol.167(1), 228–234 (2001).
   PubMedGoogle Scholar
• Phadke AP, Akangire G, Park SJ, Lira SA, Mehrad B. The role of CC chemokine receptor 6 in host defense in a model of invasive pulmonary aspergillosis. Am. J. Respir. Crit. Care Med.175(11), 1165–1172 (2007).
   PubMed Web of Science ®Google Scholar
• Schutte BC, McCray PB Jr. β-defensins in lung host defense. Annu. Rev. Physiol.64, 709–748 (2002).
   PubMed Web of Science ®Google Scholar
• Hintzen G, Ohl L, del Rio ML et al. Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node. J. Immunol.177(10), 7346–7354 (2006).
   PubMed Web of Science ®Google Scholar
• Lloyd CM, Delaney T, Nguyen T et al. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J. Exp. Med.191(2), 265–274 (2000).
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Andarini S, Xin H et al. Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila. Infect. Immun.73(9), 5350–5357 (2005).
   PubMed Web of Science ®Google Scholar
• Kahnert A, Seiler P, Stein M et al. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. Eur. J. Immunol.36(3), 631–647 (2006).
   PubMed Web of Science ®Google Scholar
• Arora S, Hernandez Y, Erb-Downward JR, McDonald RA, Toews GB, Huffnagle GB. Role of IFN-γ in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis. J. Immunol.174(10), 6346–6356 (2005).
   PubMedGoogle Scholar
• Bhan U, Trujillo G, Lyn-Kew K et al. Toll-like receptor 9 regulates the lung macrophage phenotype and host immunity in murine pneumonia caused by Legionella pneumophila. Infect. Immun.76(7), 2895–2904 (2008).
   PubMed Web of Science ®Google Scholar
• Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol.3(1), 23–35 (2003).
   PubMed Web of Science ®Google Scholar
• Netea MG, Lewis EC, Azam T et al. Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc. Natl Acad. Sci. USA105(9), 3515–3520 (2008).
   Google Scholar
• Lei D, Lancaster JR Jr, Joshi MS et al. Activation of alveolar macrophages and lung host defenses using transfer of the interferon-γ gene. Am. J. Physiol.272(5 Pt 1), L852–L859 (1997).
   Google Scholar
• Woolard MD, Hudig D, Tabor L, Ivey JA, Simecka JW. NK cells in γ-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp. Infect. Immun.73(10), 6742–6751 (2005).
   PubMed Web of Science ®Google Scholar
• Shao C, Qu J, He L et al. Transient overexpression of γ interferon promotes Aspergillus clearance in invasive pulmonary aspergillosis. Clin. Exp. Immunol.142(2), 233–241 (2005).
   Google Scholar
• Deng JC, Tateda K, Zeng X, Standiford TJ. Transient transgenic expression of γ interferon promotes Legionella pneumophila clearance in immunocompetent hosts. Infect. Immun.69(10), 6382–6390 (2001).
   PubMedGoogle Scholar
• Kolls JK, Lei D, Stoltz D et al. Adenoviral-mediated interferon-γ gene therapy augments pulmonary host defense of ethanol-treated rats. Alcohol Clin. Exp. Res.22(1), 157–162 (1998).
   Google Scholar
• Docke WD, Randow F, Syrbe U et al. Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat. Med.3(6), 678–681 (1997).
   PubMed Web of Science ®Google Scholar
• Mancuso G, Midiri A, Biondo C et al. Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J. Immunol.178(5), 3126–3133 (2007).
   PubMed Web of Science ®Google Scholar
• Chen GH, McDonald RA, Wells JC, Huffnagle GB, Lukacs NW, Toews GB. The γ interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans. Infect. Immun.73(3), 1788–1796 (2005).
   PubMed Web of Science ®Google Scholar
• Biondo C, Midiri A, Gambuzza M et al. IFN-α/β signaling is required for polarization of cytokine responses toward a protective type 1 pattern during experimental cryptococcosis. J. Immunol.181(1), 566–573 (2008).
   Google Scholar
• Durand V, Wong SY, Tough DF, Le Bon A. Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-α/β. Immunol. Cell Biol.82(6), 596–602 (2004).
   PubMed Web of Science ®Google Scholar
• Ank N, Iversen MB, Bartholdy C et al. An important role for type III interferon (IFN-λ/IL-28) in TLR-induced antiviral activity. J. Immunol.180(4), 2474–2485 (2008).
   PubMed Web of Science ®Google Scholar
• Gregory AD, Hogue LA, Ferkol TW, Link DC. Regulation of systemic and local neutrophil responses by G-CSF during pulmonary Pseudomonas aeruginosa infection. Blood109(8), 3235–3243 (2007).
   PubMed Web of Science ®Google Scholar
• Nelson S, Belknap SM, Carlson RW et al. A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group. J. Infect. Dis.178(4), 1075–1080 (1998).
   PubMedGoogle Scholar
• Cheng AC, Stephens DP, Currie BJ. Granulocyte-colony stimulating factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults. Cochrane Database Syst. Rev.2, CD004400 (2007).
   Google Scholar
• Berclaz PY, Shibata Y, Whitsett JA, Trapnell BC. GM-CSF, via PU.1, regulates alveolar macrophage Fcγ R-mediated phagocytosis and the IL-18/IFN-γ-mediated molecular connection between innate and adaptive immunity in the lung. Blood100(12), 4193–4200 (2002).
   PubMed Web of Science ®Google Scholar
• Chen GH, Olszewski MA, McDonald RA et al. Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis. Am J. Pathol.170(3), 1028–1040 (2007).
   PubMedGoogle Scholar
• Gonzalez-Juarrero M, Hattle JM, Izzo A et al. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J. Leukoc. Biol.77(6), 914–922 (2005).
   PubMed Web of Science ®Google Scholar
• Nierhaus A, Montag B, Timmler N et al. Reversal of immunoparalysis by recombinant human granulocyte–macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med.29(4), 646–651 (2003).
   PubMed Web of Science ®Google Scholar
• Presneill JJ, Harris T, Stewart AG, Cade JF, Wilson JW. A randomized Phase II trial of granulocyte–macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. Am. J. Respir. Crit. Care Med.166(2), 138–143 (2002).
   PubMed Web of Science ®Google Scholar
• Baleeiro CE, Christensen PJ, Morris SB, Mendez MP, Wilcoxen SE, Paine R 3rd. GM-CSF and the impaired pulmonary innate immune response following hyperoxic stress. Am. J. Physiol. Lung Cell. Mol. Physiol.291(6), L1246–L1255 (2006).
   PubMed Web of Science ®Google Scholar
• Moore BB, Coffey MJ, Christensen P et al. GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism. J. Immunol.165(7), 4032–4039 (2000).
   PubMed Web of Science ®Google Scholar
• Stockinger B, Veldhoen M, Martin B. Th17 cells: linking innate and adaptive immunity. Semin. Immunol.19(6), 353–361 (2007).
   PubMed Web of Science ®Google Scholar
• Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity28(4), 454–467 (2008).
   PubMed Web of Science ®Google Scholar
• Gaffen SL. An overview of IL-17 function and signaling. Cytokine43(3), 402–407 (2008).
   PubMed Web of Science ®Google Scholar
• Umemura M, Yahagi A, Hamada S et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette–Guerin infection. J. Immunol.178(6), 3786–3796 (2007).
   PubMed Web of Science ®Google Scholar
• Ye P, Rodriguez FH, Kanaly S et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med.194(4), 519–527 (2001).
   PubMed Web of Science ®Google Scholar
• Rudner XL, Happel KI, Young EA, Shellito JE. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect. Immun.75(6), 3055–3061 (2007).
   PubMed Web of Science ®Google Scholar
• Aujla SJ, Chan YR, Zheng M et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med.14(3), 275–281 (2008).
   PubMed Web of Science ®Google Scholar
• Milner JD, Brenchley JM, Laurence A et al. Impaired T(h)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature452(7188), 773–776 (2008).
   PubMed Web of Science ®Google Scholar
• Zheng Y, Danilenko DM, Valdez P et al. Interleukin-22, a T(h)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature445(7128), 648–651 (2007).
   PubMed Web of Science ®Google Scholar
• Sawa T, Corry DB, Gropper MA, Ohara M, Kurahashi K, Wiener-Kronish JP. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J. Immunol.159(6), 2858–2866 (1997).
   PubMed Web of Science ®Google Scholar
• Askenasy N, Kaminitz A, Yarkoni S. Mechanisms of T regulatory cell function. Autoimmun. Rev.7(5), 370–375 (2008).
   PubMed Web of Science ®Google Scholar
• Didierlaurent A, Goulding J, Hussell T. The impact of successive infections on the lung microenvironment. Immunology122(4), 457–465 (2007).
   PubMed Web of Science ®Google Scholar
• Holscher C, Holscher A, Ruckerl D et al. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J. Immunol.174(6), 3534–3544 (2005).
   PubMed Web of Science ®Google Scholar
• Marriott HM, Hellewell PG, Cross SS, Ince PG, Whyte MK, Dockrell DH. Decreased alveolar macrophage apoptosis is associated with increased pulmonary inflammation in a murine model of pneumococcal pneumonia. J. Immunol.177(9), 6480–6488 (2006).
   PubMed Web of Science ®Google Scholar
• Janssen WJ, McPhillips KA, Dickinson MG et al. Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP α. Am. J. Respir. Crit. Care Med.178(2), 158–167 (2008).
   PubMed Web of Science ®Google Scholar
• Tejera A, Santolaria F, Diez ML et al. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine38(3), 117–123 (2007).
   PubMed Web of Science ®Google Scholar
• Gibot S. TREM, new receptors mediating innate immunity. Med. Sci. (Paris)20(5), 503–505 (2004).
   Google Scholar
• Pai M, Menzies D. Interferon-γ release assays: what is their role in the diagnosis of active tuberculosis? Clin. Infect. Dis.44(1), 74–77 (2007).
   PubMed Web of Science ®Google Scholar